Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retros...
Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study
About this item
Full title
Author / Creator
Gao, Yan , Li, Yuan , Zhang, Chunyu , Han, Jinsong , Liang, Huamao , Zhang, Kun and Guo, Hongyan
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
To compare the chemoresistance and survival in patients with stage IIIC or IV epithelial ovarian cancer who were treated with neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) or primary debulking surgery (PDS). The clinical characteristics of patients who benefited from NACT were further evaluated.
We retrospectively...
Alternative Titles
Full title
Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_115a5ae16e13471d9858e595eb826de8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_115a5ae16e13471d9858e595eb826de8
Other Identifiers
ISSN
1757-2215
E-ISSN
1757-2215
DOI
10.1186/s13048-019-0562-9
